Literature DB >> 9706124

Diabetic retinopathy.

K A Neely1, D A Quillen, A P Schachat, T W Gardner, G W Blankenship.   

Abstract

Nonproliferative diabetic retinopathy may cause visual loss when associated with macular edema or macular ischemia (secondary to retinal capillary nonperfusion). Proliferative diabetic retinopathy may cause severe visual loss if complicated by vitreous hemorrhage or traction detachment of the macula. Patients with diabetes benefit from collaboration between the internist and ophthalmologist. Tighter control of blood glucose levels and lower blood pressure reduce the risk of progression of diabetic retinopathy. Regular dilated eye examinations and appropriate intervention with laser or vitrectomy surgery help to preserve vision in patients with established macular edema or proliferative diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706124     DOI: 10.1016/s0025-7125(05)70027-4

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  9 in total

1.  Characteristics associated with neuropathy and/or retinopathy in a hospital outpatient diabetic clinic.

Authors:  Mary T McClean; William John Andrews; James C McElnay
Journal:  Pharm World Sci       Date:  2005-06

2.  Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy.

Authors:  Mehmet Citirik; Nilufer Berker; Hulya Haksever; Ufuk Elgin; Huseyin Ustun
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 3.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

4.  Dietary wolfberry upregulates carotenoid metabolic genes and enhances mitochondrial biogenesis in the retina of db/db diabetic mice.

Authors:  Huifeng Yu; Logan Wark; Hua Ji; Lloyd Willard; Yu Jaing; Jing Han; Hui He; Edlin Ortiz; Yunong Zhang; Denis M Medeiros; Dingbo Lin
Journal:  Mol Nutr Food Res       Date:  2013-03-15       Impact factor: 5.914

5.  Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.

Authors:  Mong-Ping Shyong; Fenq-Lih Lee; Ping-Chang Kuo; Ai-Ching Wu; Huey-Chung Cheng; Show-Li Chen; Tao-Hsin Tung; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2007-01-31       Impact factor: 2.367

6.  Evaluation of Macular Thickness, Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness in Patients among Type 2 Diabetes Mellitus Using Optical Coherence Tomography.

Authors:  Kalaimamani Ezhilvendhan; Arjun Shenoy; R Rajeshkannan; SaravanaBhava Balachandrachari; Anitha Sathiyamoorthy
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

7.  Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea.

Authors:  Sang-Yeob Kim; Byeong-Yeon Moon; Hyun-Gug Cho; Dong-Sik Yu
Journal:  Int J Environ Res Public Health       Date:  2022-07-17       Impact factor: 4.614

Review 8.  Cellular signaling and potential new treatment targets in diabetic retinopathy.

Authors:  Zia A Khan; Subrata Chakrabarti
Journal:  Exp Diabetes Res       Date:  2007

9.  Cellular mechanisms of high mobility group 1 (HMGB-1) protein action in the diabetic retinopathy.

Authors:  Andrea Rachelle C Santos; Galina Dvoriantchikova; Yiwen Li; Ghulam Mohammad; Ahmed M Abu El-Asrar; Rong Wen; Dmitry Ivanov
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.